membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
05-05-26 10:53
4Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 24/02/25 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.93 | 3.70 | -46.82% | -234 | 
|
0 |
| 17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 29.20 | 88.10% | 441 |
|
0 |
| 06/11/24 | MEDINCELL SA | Achat | 400 E | 15.22 | 25.78 | 69.11% | 276 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.27 | 1.11 | -12.47% | -50 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.34 | 1.11 | -17.05% | -68 |
|
0 |
| 22/10/24 | ADOCIA | Achat | 400 E | 8.51 | 4.11 | -51.90% | -208 |
|
0 |
| 21/10/24 | ADOCIA | Achat | 400 E | 7.65 | 4.11 | -46.48% | -186 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 500 E | 2.25 | 1.20 | -46.82% | -234 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 400 E | 2.29 | 1.20 | -47.75% | -191 |
|
0 |
| 01/10/24 | ADVICENNE | Achat | 400 E | 1.62 | 1.20 | -26.10% | -104 |
|
0 |
| 30/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 8.11 | 3.70 | -54.57% | -218 |
|
0 |
| 23/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.41 | 3.70 | -50.27% | -151 |
|
0 |
| 19/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.76 | 3.70 | -52.52% | -210 |
|
0 |
| 17/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.24 | 3.70 | -49.10% | -196 |
|
0 |
| 22/08/24 | VALBIOTIS | Achat | 400 E | 1.79 | 1.11 | -37.93% | -152 |
|
0 |
| 05/06/24 | VALBIOTIS | Achat | 400 E | 2.31 | 1.11 | -51.92% | -208 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.47 | 1.20 | -51.57% | -206 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.54 | 1.20 | -52.90% | -212 |
|
24 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 14.96 | 25.78 | 72.05% | 288 |
|
0 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 15.10 | 25.78 | 70.46% | 282 |
|
0 |
| 08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 4.11 | -60.58% | -242 |
|
0 |
| 25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 3.70 | -19.31% | -77 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 1.62 | -49.68% | -199 |
|
0 |
| 18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 1.54 | -34.35% | -137 |
|
0 |
| 08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 1.11 | -82.87% | -331 |
|
0 |
| 19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.20 | -49.94% | -250 |
|
0 |
| 18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.20 | -50.56% | -202 |
|
0 |
| 14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 1.11 | -74.34% | -297 |
|
0 |
| 13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 1.54 | -52.02% | -208 |
|
0 |
| 23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 3.70 | -67.01% | -268 |
|
7 |
| 23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 1.54 | -75.08% | -300 |
|
7 |
| 21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 1.54 | -74.11% | -296 |
|
7 |
| 15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 1.11 | -86.05% | -344 |
|
7 |
| 14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 1.11 | -86.51% | -346 |
|
5 |
| 31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.20 | -90.11% | -360 |
|
7 |
| 16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 1.11 | -85.91% | -344 |
|
7 |
| 10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 1.11 | -85.38% | -256 |
|
7 |
| 04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 1.11 | -84.16% | -252 |
|
4 |
| 21/01/21 | VALBIOTIS | Achat | 300 E | 6.78 | 1.11 | -83.69% | -251 |
|
8 |
| 27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 1.54 | -65.68% | -197 |
|
8 |
| 12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 1.54 | -59.83% | -179 |
|
7 |
| 11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 1.54 | -60.14% | -180 |
|
4 |
| 10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 1.54 | -54.72% | -164 |
|
7 |
| 09/09/20 | INNATE PHARMA | Achat | 300 E | 3.68 | 1.54 | -58.29% | -175 |
|
5 |
| 25/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.80 | 3.70 | -36.44% | -109 |
|
8 |
| 30/04/20 | ADVICENNE | Achat | 300 E | 8.82 | 1.20 | -86.51% | -260 |
|
6 |
| 24/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.02 | 3.70 | -26.55% | -80 |
|
7 |
| 23/04/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 1.54 | -75.80% | -227 |
|
7 |
| 21/04/20 | INNATE PHARMA | Achat | 300 E | 6.39 | 1.54 | -76.02% | -228 |
|
7 |
| 20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.38 | 3.70 | -15.80% | -47 |
|
6 |
| Enregistrements 1 à 50 sur 54 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 12/03/20 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.97 | 1.24 | -37.22% | -112 |  |
3 |
| 12/03/20 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.96 | 1.24 | -36.90% | -111 | |
2 |
| 12/03/20 | THERADIAG | Achat | 300 E | 1.82 | 1.20 | -34.23% | -103 | |
5 |
| 12/03/20 | THERADIAG | Achat | 300 E | 1.84 | 1.15 | -37.66% | -113 | |
5 |
| 12/03/20 | ADVICENNE | Achat | 300 E | 8.80 | 6.26 | -29.03% | -87 | |
7 |
| 12/03/20 | YMAGIS | Achat | 300 E | 2.13 | 1.00 | -53.20% | -160 | |
9 |
| 12/03/20 | YMAGIS | Achat | 300 E | 2.02 | 1.00 | -50.64% | -152 | |
8 |
| 12/03/20 | YMAGIS | Achat | 300 E | 1.94 | 1.00 | -48.61% | -146 | |
8 |
| 12/03/20 | YMAGIS | Achat | 300 E | 2.03 | 1.00 | -50.89% | -153 | |
8 |
| 12/03/20 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.87 | 1.20 | -35.99% | -108 | |
3 |
| 12/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.68 | 3.40 | -7.80% | -23 | |
7 |
| 12/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.80 | 3.40 | -10.72% | -32 | |
9 |
| 12/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.89 | 3.40 | -12.78% | -38 | |
8 |
| 12/03/20 | IT LINK | Achat | 600 E | 15.60 | 10.20 | -34.78% | -209 | |
20 |
| 12/03/20 | IT LINK | Achat | 600 E | 15.92 | 10.20 | -36.09% | -217 | |
13 |
| 12/03/20 | ACTIA GROUP | Achat | 300 E | 3.92 | 2.60 | -33.84% | -102 | |
5 |
| 12/03/20 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.61 | 0.97 | -39.91% | -120 | |
2 |
| 12/03/20 | ESKER | Achat | 300 E | 83.50 | 90.90 | 8.65% | 26 | |
11 |
| 12/03/20 | INNATE PHARMA | Achat | 200 E | 8.40 | 4.97 | -40.99% | -82 | |
7 |
| 12/03/20 | EUROFINS SCIENTIFIC SE | Achat | 300 E | 472.20 | 418.80 | -11.50% | -35 | |
8 |
| 12/03/20 | EUROFINS SCIENTIFIC SE | Achat | 300 E | 475.80 | 418.80 | -12.17% | -37 | |
29 |
| 12/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 200 E | 7.75 | 3.97 | -48.93% | -98 | |
4 |
| 11/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 4.41 | 4.65 | 5.24% | 105 | |
2 |
| 11/03/20 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.83 | 1.44 | -21.49% | -64 | |
3 |
| 09/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.69 | 4.23 | 14.35% | 287 | |
2 |
| 09/03/20 | ADVICENNE | Achat | 300 E | 10.50 | 8.40 | -20.18% | -61 | |
10 |
| 09/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 6.95 | 4.47 | -35.85% | -108 | |
4 |
| 09/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 7.05 | 4.47 | -36.76% | -110 | |
5 |
| 09/03/20 | ADOCIA | Achat | 300 E | 19.50 | 7.53 | -61.52% | -185 | |
3 |
| 09/03/20 | ADOCIA | Achat | 300 E | 12.84 | 7.53 | -41.51% | -125 | |
2 |
| 09/03/20 | ADOCIA | Achat | 300 E | 16.80 | 7.53 | -55.32% | -166 | |
10 |
| 09/03/20 | THERADIAG | Achat | 300 E | 1.06 | 1.32 | 24.30% | 73 | |
5 |
| 06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.82 | 3.81 | -0.46% | -9 | |
2 |
| 06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.68 | 3.81 | 3.33% | 67 | |
2 |
| 06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.68 | 3.78 | 2.51% | 50 | |
2 |
| 06/03/20 | EUROFINS SCIENTIFIC SE | Vente | 2 000 E | 505.50 | 450.80 | 10.56% | 211 | |
3 |
| 06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.64 | 3.78 | 3.55% | 71 | |
3 |
| 06/03/20 | INNATE PHARMA | Achat | 300 E | 6.07 | 6.28 | 3.26% | 10 | |
4 |
| 06/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.78 | 3.75 | -0.99% | -3 | |
7 |
| 06/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.04 | 3.75 | -7.37% | -22 | |
6 |
| 06/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.06 | 3.75 | -7.83% | -23 | |
8 |
| 05/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.55 | 3.39 | -4.77% | -95 | |
3 |
| 05/03/20 | EUROFINS SCIENTIFIC SE | Vente | 2 000 E | 513.00 | 492.80 | 3.71% | 74 | |
4 |
| 04/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.72 | 3.48 | -6.65% | -133 | |
3 |
| 03/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 6.05 | 5.43 | -10.44% | -31 | |
2 |
| 03/03/20 | ADOCIA | Achat | 2 000 E | 12.76 | 9.10 | -29.34% | -587 | |
2 |
| 02/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 9.92 | 5.29 | -46.83% | -140 | |
13 |
| 02/03/20 | INNATE PHARMA | Achat | 600 E | 9.52 | 6.50 | -31.89% | -191 | |
12 |
| 02/03/20 | ACTIA GROUP | Achat | 300 E | 4.32 | 3.19 | -26.33% | -79 | |
4 |
| 02/03/20 | ACTIA GROUP | Achat | 300 E | 3.94 | 3.19 | -19.22% | -58 | |
4 |
| Enregistrements 701 à 750 sur 1162 | |||||||||